REVENUES

6 Months Ended

Jun. 30, 2022

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended June 30,				Six Months Ended June 30,
(U.S. dollars in thousands)	2022		2021		2022		2021
Pfizer	$	3,382	$	2,237	$	6,738	$	6,748
Brazil	$	-	$	988	$	5,454	$	988
Chiesi	$	-	$	18	$	218	$	18
Total revenues from selling goods	$	3,382	$	3,243	$	12,410	$	7,754
Revenues from license and R&D services	$	5,371	$	3,184	$	12,428	$	9,993